183 related articles for article (PubMed ID: 2203313)
1. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
4. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
5. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
Mitsuhashi S
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Yoshida M; Mitsuhashi S
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):625-9. PubMed ID: 2209630
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Petersen PJ; Jacobus NV; Weiss WJ; Testa RT
Antimicrob Agents Chemother; 1991 Jan; 35(1):203-7. PubMed ID: 1901698
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity and beta-lactamase stability of LJC 10,627.
Neu HC; Gu JW; Fang W; Chin NX
Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
[TBL] [Abstract][Full Text] [Related]
19. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
Maejima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
